1260168-75-9

Upstream product

• 104029-20-1 ethyl 3-(5-chloro-2-methoxyphenyl)-3-oxopropanoate 
• 1260168-73-7 ethyl 2-(5-chloro-2-methoxybenzoyl)-3-(dimethylamino)acrylate 
• 3438-16-2 5-chloro-2-methoxybenzoic acid 

Downstream Products

• 1260168-77-1 ethyl 3-(5-chloro-2-methoxyphenyl)-1-methyl-1H-pyrazole-4-carboxylate 
• 1260168-79-3 ethyl 5-(5-chloro-2-methoxyphenyl)-1-methyl-1H-pyrazole-4-carboxylate 
• 1260168-85-1 C₁₂H₁₁ClN₂O₃ 
• 1260168-87-3 tert-butyl 5-(5-chloro-2-methoxyphenyl)-1-methyl-1H-pyrazol-4-ylcarbamate 
• 1260168-81-7 tert-butyl 3-(5-chloro-2-methoxyphenyl)-1-methyl-1H-pyrazol-4-ylcarbamate 
• 1260168-83-9 C₁₂H₁₁ClN₂O₃ 
• 1260168-88-4 3-(5-chloro-2-methoxyphenyl)-1-methyl-1H-pyrazol-4-amine 

Relevant academic research and scientific papers

PYRAZOLOCHLOROPHENYL COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF

Compounds of Formula (I) and methods of use as Janus kinase inhibitors are described herein.

PYRAZOLOPYRIMIDINE JAK INHIBITOR COMPOUNDS AND METHODS

A compound of Formula I, enantiomers, diasteriomers, tautomers or pharmaceutically acceptable salts thereof, wherein R1, R2 and R3 are defined herein, are useful as inhibitors of one or more Janus kinases. A pharmaceutical